WebDisclosure WebDisclosure
Basculer en Français
8701 Companies
151348 Keywords
86988 Articles
81272 Press releases
Headlines Articles Press releases Neurocare Group Remove
  1. Home
  2. Companies
  3. Neurocare Group
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/21/2024 at 14:20, 6 months 14 days ago

    Neurocare Group Announces Kevin Reeder as New CFO

    Growth Strategy Chief Financial Officer Mental Health Neurocare Group Kevin Reeder
  • BRIEF

    published on 11/21/2024 at 14:20, 6 months 14 days ago

    Neurocare Group annonce la nomination de Kevin Reeder au poste de directeur financier

    Stratégie De Croissance Santé Mentale Directeur Financier Kevin Reeder Groupe Neurocare
  • PRESS RELEASE

    published on 11/21/2024 at 14:15, 6 months 14 days ago

    neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

    neurocare group AG appoints Kevin Reeder as Chief Financial Officer starting January 1st, 2025. Reeder, with an MBA from Oxford University, brings vast international investment management experience
    Chief Financial Officer Appointment Neurocare Group AG Kevin Reeder International Investment Management
Accesswire
  • Published on 06/05/2025 at 14:00, 22 minutes ago

    Brenmiller Energy CEO Provides Update On Milestones Powering Progress

  • Published on 06/05/2025 at 13:30, 52 minutes ago

    ROK Resources Announces Normal Course Issuer Bid

  • Published on 06/05/2025 at 13:00, 1 hour 22 minutes ago

    Eagle Plains Announces Uplisting to OTCQB Venture Market

  • Published on 06/05/2025 at 13:00, 1 hour 22 minutes ago

    Axo Copper Initiates Phase II Drilling Program to Follow Up on Successful Phase I Program Which Included Highlights of 8.9 Metres of 5.87% Copper and 15.4 Metres of 3.86% Copper

  • Published on 06/05/2025 at 13:00, 1 hour 22 minutes ago

    CoTec Investment Ceibo Successfully Produces Copper Cathodes at Demo Plant, Marking a Major Milestone in Copper Sulfide Leaching Technology

View all ACCESSWIRE
EQS Group
  • Published on 06/05/2025 at 14:00, 22 minutes ago

    ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease

  • Published on 06/05/2025 at 13:57, 25 minutes ago

    naoo AG Launches New App Version with Major Performance Boost and Additional Features

  • Published on 06/05/2025 at 13:55, 27 minutes ago

    INDUS adds U.S. fabrication and engineering expertise through strategic acquisition

  • Published on 06/05/2025 at 13:38, 44 minutes ago

    Dalata Hotel Group PLC: HOL-Holding(s) in Company*

  • Published on 06/05/2025 at 13:34, 47 minutes ago

    Original-Research: Ernst Russ AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy

View all EQS
Les Echos
  • Published on 06/05/2025 at 10:04, 4 hours 18 minutes ago

    LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/05/2025

  • Published on 06/05/2025 at 09:58, 4 hours 24 minutes ago

    Déclaration du nombre d’actions et droits de vote au 31 mai 2025

  • Published on 06/05/2025 at 09:58, 4 hours 24 minutes ago

    Disclosure of Share Capital and Voting Rights as of May 31, 2025

  • Published on 06/04/2025 at 18:05, 20 hours 17 minutes ago

    Déclaration nombre d'actions et droits de vote - 04.06.2025

  • Published on 06/04/2025 at 18:05, 20 hours 17 minutes ago

    Disclosure of shares outstanding and voting rights - 04.06.2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy